Arzeda

Arzeda

Develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Seed
N/A

$149k

Grant
*

$610k

Grant
N/A

$1.0m

Grant
*

$1.3m

Grant

$3.2m

Series A
*

$12.0m

Series A
N/A

N/A

-

$6.0m

Series B
*

$33.0m

Series B
*
N/A

$14.9m

Valuation: $165m

Late VC
*

$38.0m

Late VC
Total Funding$110m

Recent News about Arzeda

Edit
More about Arzedainfo icon
Edit

Arzeda is a biotechnology company specializing in the computational design of proteins to create sustainable and high-performance chemicals. Operating in the industrial biotechnology market, Arzeda serves clients across various sectors including chemicals, materials, and consumer goods. The company's business model revolves around leveraging its proprietary technology to design custom proteins and fermentation strains, enabling the production of novel molecules that are otherwise inaccessible through natural diversity or synthetic chemistry. Arzeda generates revenue through partnerships, licensing agreements, and collaborative projects with industry leaders such as Unilever and Amyris. By optimizing and differentiating bioproducts, Arzeda aims to improve economic efficiency and market penetration for its clients.

Keywords: computational protein design, sustainable chemicals, biotechnology, industrial production, enzyme design, fermentation strains, novel molecules, partnerships, licensing, market differentiation.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.